최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Vaccine, v.27 suppl.4, 2009년, pp.D86 - D89
Noad, R. (Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, United Kingdom) , Roy, P.
Once thought largely restricted to India and Africa, the insect-borne livestock pathogen Bluetongue virus is now present on every continent with the exception of Antarctica. Outbreaks of the disease caused by the virus in Europe over the last decade, and the resulting impact on trade and agriculture...
Prev Vet Med Mellor 87 October (1-2) 4 2008 10.1016/j.prevetmed.2008.06.002 Bluetongue in Europe and the Mediterranean Basin: history of occurrence prior to 2006
Clin Infect Dis Gubler 45 October (8) 1039 2007 10.1086/521911 The continuing spread of West Nile virus in the western hemisphere
Adv Virus Res Vasilakis 72 1 2008 10.1016/S0065-3527(08)00401-6 The history and evolution of human dengue emergence
Prev Vet Med Elbers 87 October (1-2) 31 2008 10.1016/j.prevetmed.2008.06.003 Field observations during the Bluetongue serotype 8 epidemic in 2006. II. Morbidity and mortality rate, case fatality and clinical recovery in sheep and cattle in the Netherlands
Transbound Emerg Dis Vercauteren 55 September (7) 293 2008 10.1111/j.1865-1682.2008.01034.x Bluetongue virus serotype 8-associated congenital hydranencephaly in calves
Prog Clin Biol Res Huismans 178 347 1985 Immune response against the purified serotype specific antigen of bluetongue virus and initial attempts to clone the gene that codes for the synthesis of this protein
Onderstepoort J Vet Sci Anim Ind Alexander 25 3 1951 The use of egg attenuated bluetongue virus in the production of a polyvalent vaccine for sheep: a propagation of the virus in sheep
Vet Rec Parker 96 March (13) 284 1975 10.1136/vr.96.13.284 An experimental inactivated vaccine against bluetongue
Vaccine Campbell 3 December (5) 401 1985 10.1016/0264-410X(85)90131-8 Immunogenicity of bluetongue virus inactivated by gamma irradiation
Onderstepoort J Vet Res Hunter 68 December (4) 331 2001 A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep
Am J Vet Res Lacetera 65 October (10) 1331 2004 10.2460/ajvr.2004.65.1331 Evaluation of antibody response and nonspecific lymphocyte blastogenesis following inoculation of a live attenuated bluetongue virus vaccine in goats
Comp Immunol Microbiol Infect Dis Savini 31 March (2-3) 101 2008 10.1016/j.cimid.2007.07.006 Vaccines against bluetongue in Europe
Nat Rev Microbiol Roy 7 February (2) 120 2009 10.1038/nrmicro2052 Prospects for improved bluetongue vaccines
Vaccine Roy 12 July (9) 805 1994 10.1016/0264-410X(94)90289-5 Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection
J Virol Roy 64 May (5) 1998 1990 10.1128/JVI.64.5.1998-2003.1990 Recombinant virus vaccine for bluetongue disease in sheep
Virology Loudon 182 June (2) 793 1991 10.1016/0042-6822(91)90620-Q Expression of the outer capsid protein VP5 of two bluetongue viruses, and synthesis of chimeric double-shelled virus-like particles using combinations of recombinant baculoviruses
Vaccine Roy 10 1 28 1992 10.1016/0264-410X(92)90415-G Protective efficacy of virus-like particles for bluetongue disease
Methods Xiang 40 September (1) 1 2006 10.1016/j.ymeth.2006.05.016 Pathogen recognition and development of particulate vaccines: does size matter?
Int J Med Microbiol Nassal 298 January (1-2) 135 2008 10.1016/j.ijmm.2007.08.002 Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines
Vet Immunol Immunopathol Lobato 59 November (3-4) 293 1997 10.1016/S0165-2427(97)00084-6 Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens
Vaccine Boone 25 January (4) 672 2007 10.1016/j.vaccine.2006.08.025 Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep
Virology Wade-Evans 220 June (1) 227 1996 10.1006/viro.1996.0306 Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge
Vet Ther Siger 7 Fall (3) 249 2006 Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses
Arch Virol Minke 18 Suppl 221 2004 Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge
Am J Vet Res Minke 68 February (2) 213 2007 10.2460/ajvr.68.2.213 Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge
Vet Rec Poulet 153 August (5) 141 2003 10.1136/vr.153.5.141 Efficacy of a canarypox virus-vectored vaccine against feline leukaemia
Curr Opin Mol Ther Rees 4 February (1) 49 2002 Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer
Vaccine Schleiss 24 September (37-39) 6175 2006 10.1016/j.vaccine.2006.06.077 Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine
J Virol Boyce 81 March (5) 2179 2007 10.1128/JVI.01819-06 Recovery of infectious bluetongue virus from RNA
J Virol Boyce 82 September (17) 8339 2008 10.1128/JVI.00808-08 Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts
J Virol Matsuo 2009 10.1128/JVI.00465-09 Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimaeric virus formation
J Virol Celma 83 July (13) 6806 2009 10.1128/JVI.00263-09 A viral nonstructural protein regulates bluetongue virus trafficking and release
※ AI-Helper는 부적절한 답변을 할 수 있습니다.